Safety, Tolerability, and Pharmacokinetics of Proxalutamide Therapy in Women With Metastatic Breast Cancer
|
|
文献详情
编号/登记号：
注册时间：
研究开始时间：
研究结束时间：
项目类型：
本院角色：
多中心研究：
招募状态：
试验分期：
研究疾病/适应症：
研究类型：
研究单位：[1]Suzhou Kintor Pharmaceutical Inc[2]Sun-Yat-sen University Cancer center Guangzhou, Fujian, China[3]The Fourth Hospital of Hebei Medical University Shijiazhuang, Hebei, China河北医科大学第四医院[4]Hunan Cancer Hospital Changsha, Hunan, China[5]Jiangsu Province Hospital Nanjing, Jiangsu, China[6]Ruijin Hospital, Shanghai Jiaotong University School of Medicine Shanghai, Shanghai, China[7]Tianjin Medical University Cancer Institute and Hospital Tianjin, Tianjin, China[8]Beijing Cancer Hospital Beijing, Beijing, China, 100142
This study is a multi-center, open-label, dose-esclation I/Ib clinical study to explore safety, efficacy an pharmacokinetics of proxalutamide in patients with metastatic breast cancer.
This study includes two stages, stage I: single- and multiple-dose tolerance and pharmacokinetic study； stage 2: preliminary efficacy and safety study.
